Correlation Between Edgewise Therapeutics and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Edgewise Therapeutics and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Adaptimmune Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Adaptimmune Therapeutics
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Adaptimmune is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Adaptimmune Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.38 times more return on investment than Adaptimmune Therapeutics. However, Edgewise Therapeutics is 2.65 times less risky than Adaptimmune Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.1 per unit of risk. If you would invest 3,481 in Edgewise Therapeutics on August 24, 2024 and sell it today you would lose (283.00) from holding Edgewise Therapeutics or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Edgewise Therapeutics |
| Adaptimmune Therapeutics |
Edgewise Therapeutics and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Adaptimmune Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Edgewise Therapeutics vs. ZyVersa Therapeutics | Edgewise Therapeutics vs. Sonnet Biotherapeutics Holdings | Edgewise Therapeutics vs. Zura Bio Limited | Edgewise Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |